A52 BUTYRATE SUPPLEMENTATION AMELIORATES DAMAGE CAUSED BY ENTERIC CITROBACTER RODENTIUM INFECTION

BACKGROUND: Patients with inflammatory bowel disease (IBD) often display a dysbiotic microbiome as well as a defective intestinal mucus layer, which appears thinner and more penetrable than the mucus layer of healthy subjects. Tributyrin (TB), a prodrug of butyric acid, has shown beneficial effects...

Full description

Saved in:
Bibliographic Details
Published in:J Can Assoc Gastroenterol
Main Authors: Celiberto, L S, Healey, G, Xu, J, Xia, L, Vallance, B
Format: Artigo
Language:Inglês
Published: Oxford University Press 2020
Subjects:
Poster of Distinction
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7043417/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz047.051
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items